Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.03
11.11.21
€2.90
11.11.22
-21.78%
28.04.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.98
09.11.21
€12.00
09.11.22
-4.84%
10.07.22

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€11.19
08.11.21
€10.00
08.11.22
-52.24%
14.03.22

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.17
03.11.21
-
03.11.22
-8.41%
15.11.21

Risky Investment
Canopy Growth Corp

Start price
Target price
Perf. (%)
€11.11
01.11.21
€10.00
01.11.22
0.67%
08.11.21

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€6.93
01.11.21
€10.80
01.11.22
-21.90%
05.12.21

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.86
27.10.21
€40.00
31.12.23
-59.32%
08.05.23

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€30.01
25.10.21
-
25.10.22
-1.37%
31.10.21

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€12.28
22.10.21
€19.00
22.10.22
-38.19%
08.01.22

buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.86
21.10.21
€7.00
21.10.22
0.93%
13.08.22

buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.88
21.10.21
€10.00
21.10.22
-31.88%
22.10.22

buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.45
18.10.21
€12.00
31.12.23
-2.68%
08.05.23

Could be very worthwhile Investment >20% year
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.88
15.10.21
€12.00
15.10.23
-6.12%
15.06.22

Edesa Biotech Inc

Start price
Target price
Perf. (%)
€7.09
15.10.21
€2.00
15.10.22
-76.35%
15.06.22

Edesa Biotech Inc

Start price
Target price
Perf. (%)
€7.09
15.10.21
-
15.10.22
-86.10%
15.10.22

Edesa Biotech Inc

Start price
Target price
Perf. (%)
€7.09
15.10.21
€3.00
15.10.22
-76.35%
15.06.22

buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.90
13.10.21
€9.20
13.10.24
5.06%
14.06.22

Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Undervalued
Very positive Cash Flow expected
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.88
13.10.21
€9.50
13.10.24
-5.48%
15.06.22

buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.87
13.10.21
€10.00
13.10.24
-4.83%
15.06.22

Leading role in innovation
Capable Management
Good culture
Strong uniques
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.88
13.10.21
€7.00
13.10.22
7.44%
14.06.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.88
13.10.21
€8.50
13.10.22
-1.14%
13.10.21

Leading role in innovation
Capable Management
Good culture
Strong uniques
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.95
10.10.21
€8.00
31.12.23
58.11%
13.12.21

Could be very worthwhile Investment >20% year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.49
10.10.21
€5.00
31.12.23
-32.83%
08.05.23

Could be very worthwhile Investment >20% year
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.00
05.10.21
-
05.10.22
-10.00%
08.12.21

Probably not worthwhile Investment
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.40
04.10.21
-
04.10.22
45.45%
10.08.22

Could be worthwhile Investment >10% per year